https://www.selleckchem.com/products/sp-13786.html
To describe the outcomes of patients with newly diagnosed neovascular age-related macular degeneration (nAMD) treated in Palmerston North over the past two years. A large prospective database was developed to capture the treatment and visual outcomes of patients with newly diagnosed nAMD. Data were subsequently extracted and analysed according to the result-based accountability (RBA) framework. Fifty-three patients in 2018 and 40 patients in 2019 were identified as having newly diagnosed nAMD. On average, there was an improvement in du
Like
Comment
Share
